NEPHROS INC (NEPH) Form SCHEDULE 13D/A — Sep 16, 2026
Wexford Capital LP and its affiliates filed Amendment No. 12 to their Schedule 13D on Nephros, reporting beneficial ownership of just 223,539 shares, or 2.06%, of Nephros common stock, down from a position above five percent. The reduction resulted from a September 14, 2026 in-kind distribution of Nephros shares from Wexford Partners 11, Wexford 11 Advisors and WPIC 2 to their underlying investors, along with a sale of shares to an entity controlled by Nephros director and former Wexford employee Arthur Amron.
Key figures
- Shares Outstanding
- 10860120
- Amendment Number
- 12
- Original13 DFiled
- 2007-10-01
- Ownership Percent
- 2.06%
- Beneficial Shares Owned
- 223539
- Shares Outstanding As Of
- 2026-08-07
- Ceased Five Percent Ownership Date
- 2026-09-14
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.